Evidence map›Paper›PMID 32923148›Full record

ArticleOncoimmunology2020

Identification of tumor-infiltrating immune cells and prognostic validation of tumor-infiltrating mast cells in adrenocortical carcinoma: results from bioinformatics and real-world data.

Xi Tian, Wenhao Xu, Yuchen Wang, Aihetaimujiang Anwaier, Hongkai Wang, Fangning Wan, Yu Zhu, Dalong Cao, Guohai Shi, Yiping Zhu and 3 more

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Frontiers in oncology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Xi TianDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Wenhao XuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yuchen WangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Aihetaimujiang AnwaierDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Hongkai WangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Fangning WanDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yu ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Dalong CaoDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Guohai ShiDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yiping ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Yuanyuan QuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Hailiang ZhangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai, China.
Shanghai Medical College of Fudan University · CNFudan University Shanghai Cancer Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The purpose of this study was to explore the composition of tumor-infiltrating immune cells (TIIC) and prognostic significance of tumor-infiltrating mast cells (TIMC) in adrenocortical carcinoma (ACC). Methods: The gene expression profiles of ACC were downloaded from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GSE90713, GSE12368). The abundance of TIICs in ACC samples was calculated by CIBERSORT algorithm and immunohistochemistry was used to identify mast cells of 39 tumor samples from Fudan University Shanghai Cancer Center (FUSCC). Differentially expressed genes (DEGs) were analyzed by LIMMA package using R software. Survival analysis was analyzed by Kaplan-Meier method and Cox regression models. Results: The abundance of mast cells ( Conclusion: In conclusion, higher TIMC infiltration was positively correlated with ACC patients' outcome in both TCGA and FUSCC cohort. Lower TIMC infiltration and elevated expression of hub genes (

Indexed as

Adrenal Cortex NeoplasmsAdrenocortical CarcinomaCell Cycle ProteinsChinaChromosomal Proteins, Non-HistoneComputational BiologyFemaleGene Expression Regulation, NeoplasticHumansKinesinsMaleMast CellsPrognosisCell Cycle ProteinsCep55 protein, humanChromosomal Proteins, Non-HistoneKIF18A protein, humanKinesinsSKA1 protein, humanAdrenocortical carcinomaCIBERSORTdifferentially expressed genestumor infiltrating immune cellstumor infiltrating mast cells

Identifiers

PMID32923148
PMCPMC7458645
OpenAlexW3037303967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.